Pathologic findings from the national surgical adjuvant breast project (NSABP) protocol B-17. Intraductal carcinoma (ductal carcinoma in situ)
1995334 citationsJournal Articlebronze Open Access
Field-Weighted Citation Impact: 9.90
Pathologic findings from the national surgical adjuvant breast project (NSABP) protocol B-17. Intraductal carcinoma (ductal carcinoma in situ) | Researchclopedia